Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study
D. S. Krupashankar,Sunil Dogra,Mahendra M. Kura,Abir Saraswat,Leelavathy Budamakuntla,T K Sumathy,Radha Shah,M.G. Gopal,T. Narayana Rao,CR Srinivas,RameshM Bhat,Narendra J. Shetty,G. Manmohan,Kotla Sai Krishna,Dalavoi Padmaja,D. V. S. Pratap,Vijay Kumar Garg,Sandesh Gupta,Neeraj Pandey,Uday Khopkar
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Kao
Samuel
yjh123
Copyright
arniu2008
OK
行走的荷尔蒙
无极微光
Nexus
学术文献互助
sagitar
研友_ZbM2qn
悦耳白山
蓝天
GG
科研狗
初景
GingerF
sanvva
皖公网安备34019202002308
